Lentiviral Vectors Market, By Product Type (1st-generation, 2nd-generation, and 3rd-generation), By Indication (HIV, ß-thalassemia, X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy, and Wiskott-Aldrich Syndrome), By End User (Hospitals, Clinics

Lentiviral Vectors Market, By Product Type (1st-generation, 2nd-generation, and 3rd-generation), By Indication (HIV, β-thalassemia, X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy, and Wiskott-Aldrich Syndrome), By End User (Hospitals, Clinics, and Research Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Lentiviral vectors are potential gene transfer vehicles used in both research and gene therapy applications. Lentiviral vectors have the capacity to stably express a gene of interest in non-dividing and diving cells, which makes them efficient vehicles for gene transfer. Lentiviral vectors are used for the treatment of various rare genetic disorders such as β-thalassemia, X-linked Adrenoleukodystrophy, X-linked severe combined immunodeficiency (SCID-X1) and Metachromatic Leukodystrophy. Moreover, various market players are focusing on increasing their research and development activities for gene therapies including lentiviral vectors, in order to enhance their product portfolio, which is expected to drive growth of the global lentiviral vectors market over the forecast period. For instance, in May, 2019, Avrobio Inc. initiated a phase I/II trial for lentiviral vector gene therapy including AVR-RD-02 for patients with type 1 Gaucher disease.

Market Dynamics

Market players are focusing on adopting various inorganic growth strategies such as agreements, acquisitions, partnerships, and collaborations, in order to strengthen their market presence, which is expected to drive growth of the global lentiviral vectors market over the forecast period. For instance, on April 07, 2020, SIRION Biotech GmbH announced that it entered into an agreement with Beam Therapeutics, a biotechnology company, which is focusing on the use of CRISPR technology for the development of advanced genetic medicines. Under this agreement, SIRION Biotech GmbH provided the non-exclusive access of its proprietary lentiviral transduction enhancer LentiBOOST, to Beam Therapeutics for clinical development and commercialization of CAR-T programs.

Key features of the study:

  • This report provides in-depth analysis of the global lentiviral vectors market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global lentiviral vectors market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Sirion-Biotech GmbH, Vigene Biosciences, OriGene Technologies, Inc., SignaGen Laboratories, Sino Biological Inc., Takara Bio Inc., Cell Biolabs, Inc., GenTarget Inc., GENEMEDI, and bluebird bio, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global lentiviral vectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lentiviral vectors market
Detailed Segmentation:
  • Global Lentiviral Vectors Market, By Product Type:
  • 1st-generation
  • 2nd-generation
  • 3rd-generation
  • Global Lentiviral Vectors Market, By Indication:
  • HIV
  • β-thalassemia
  • X-linked Adrenoleukodystrophy
  • Metachromatic Leukodystrophy
  • Wiskott-Aldrich Syndrome
  • Global Lentiviral Vectors Market, By End User:
  • Hospitals
  • Clinics
  • Research Institutes
  • Global Lentiviral Vectors Market, By Region:
  • North America
  • By Product Type:
  • 1st-generation
  • 2nd-generation
  • 3rd-generation
  • By Indication
  • HIV
  • β-thalassemia
  • X-linked Adrenoleukodystrophy
  • Metachromatic Leukodystrophy
  • Wiskott-Aldrich Syndrome
  • By End User:
  • Hospitals
  • Clinics
  • Research Institutes
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Product Type:
  • 1st-generation
  • 2nd-generation
  • 3rd-generation
  • By Indication
  • HIV
  • β-thalassemia
  • X-linked Adrenoleukodystrophy
  • Metachromatic Leukodystrophy
  • Wiskott-Aldrich Syndrome
  • By End User:
  • Hospitals
  • Clinics
  • Research Institutes
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Product Type:
  • 1st-generation
  • 2nd-generation
  • 3rd-generation
  • By Indication
  • HIV
  • β-thalassemia
  • X-linked Adrenoleukodystrophy
  • Metachromatic Leukodystrophy
  • Wiskott-Aldrich Syndrome
  • By End User:
  • Hospitals
  • Clinics
  • Research Institutes
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type:
  • 1st-generation
  • 2nd-generation
  • 3rd-generation
  • By Indication
  • HIV
  • β-thalassemia
  • X-linked Adrenoleukodystrophy
  • Metachromatic Leukodystrophy
  • Wiskott-Aldrich Syndrome
  • By End User:
  • Hospitals
  • Clinics
  • Research Institutes
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Product Type:
  • 1st-generation
  • 2nd-generation
  • 3rd-generation
  • By Indication
  • HIV
  • β-thalassemia
  • X-linked Adrenoleukodystrophy
  • Metachromatic Leukodystrophy
  • Wiskott-Aldrich Syndrome
  • By End User:
  • Hospitals
  • Clinics
  • Research Institutes
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type:
  • 1st-generation
  • 2nd-generation
  • 3rd-generation
  • By Indication
  • HIV
  • β-thalassemia
  • X-linked Adrenoleukodystrophy
  • Metachromatic Leukodystrophy
  • Wiskott-Aldrich Syndrome
  • By End User:
  • Hospitals
  • Clinics
  • Research Institutes
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Thermo Fisher Scientific*
  • Company Overview
  • Material Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Sirion-Biotech GmbH
  • Vigene Biosciences
  • OriGene Technologies, Inc.
  • SignaGen Laboratories
  • Sino Biological Inc.
  • Takara Bio Inc.
  • Cell Biolabs, Inc.
  • GenTarget Inc.
  • GENEMEDI
  • bluebird bio, Inc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Indication
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
PEST Analysis
4. Global Lentiviral Vectors Market – Impact of Coronavirus (Covid-19) Pandemic
Pre COVID-19 Market Scenario
Post COVID-19 Market Scenario
Overall Impact on Healthcare Market
Clinical Trial Analysis
1. Global Lentiviral Vectors Market, By Product Type, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
1st-generation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
2nd-generation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
3rd-generation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
2. Global Lentiviral Vectors Market, By Indication, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
HIV
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
β-thalassemia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
X-linked Adrenoleukodystrophy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Metachromatic Leukodystrophy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Wiskott-Aldrich Syndrome
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
3. Global Lentiviral Vectors Market, By End User, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
4. Global Lentiviral Vectors Market, By Region, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2020 and 2027 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2027
North America
Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
South Africa
Central Africa
North Africa
5. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Thermo Fisher Scientific
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
Sirion-Biotech GmbH
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
Vigene Biosciences
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
OriGene Technologies, Inc.
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
SignaGen Laboratories
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
Sino Biological Inc.
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
Takara Bio Inc
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
Cell Biolabs, Inc.
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
GenTarget Inc.
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
GENEMEDI
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
bluebird bio, Inc.
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
6. Section
References
Research Methodology
About us and Sales Contact
*Browse 54 market data tables and 48 figures on "Lentiviral Vectors Market” - Global forecast to 2027

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook